Jin Y, Li S, Li S. Balancing remission durability and treatment burden in older acute myeloid leukemia. Comment on: "Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia". haematol [Internet]. 2020Sep.10 [cited 2026Jul.29];. Available from: https://haematologica.org/article/view/14319